Amid the tragedy of 2020’s global COVID-19 pandemic, it’s easy to forget the horrors inflicted on hundreds of
Duchenne’s Muscular Dystrophy (DMD) is a devastating generic muscular wasting disorder with a 100% fatality rate . At
Antisense Therapeutics (ASX: ANP) is an Australian biotechnology company, developing and commercializing antisense pharmaceuticals for large unmet markets
Prescient Therapeutics (ASX:PTX) are focused on developing novel, personalised therapies for a range of cancers through universal CAR-T
In the battle against blood cancer, chimeric antigen receptor T cell (CAR-T) therapy is proving to be a
A main priority for many boards of large companies in recent years has been risk management, following a
Orthocell's (ASX: OCC) regenerative device, CelGro, is helping give mobility back to quadriplegic patients.
Orthocell Limited (ASX: OCC) is a world-leading regenerative medicine company providing innovative products to restore mobility, function and